|
|
|
Volumn 8, Issue 2, 2003, Pages 49-55
|
|
Amprenavir in pre-treated patients: virological and immunological response in a cohort of 45 patients.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPRENAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CARBAMIC ACID DERIVATIVE;
PROTEINASE INHIBITOR;
RITONAVIR;
SULFONAMIDE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
GENETICS;
GENOTYPE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
MALE;
MICROBIOLOGICAL EXAMINATION;
MIDDLE AGED;
MUTATION;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
VIREMIA;
VIROLOGY;
VIRUS LOAD;
ANTI-HIV AGENTS;
CARBAMATES;
CD4 LYMPHOCYTE COUNT;
DRUG RESISTANCE, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
GENOTYPE;
HIV;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
MUTATION;
PROSPECTIVE STUDIES;
RITONAVIR;
SULFONAMIDES;
TREATMENT OUTCOME;
VIRAL LOAD;
VIREMIA;
|
|
EID: 0043240400
PISSN: 09492321
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
